HF
EVLV icon

HRT Financial’s Evolv Technologies EVLV Stock Holding History

HRT Financial’s Portfolio EVLV Stock Details EVLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-120,870
Closed -$865K – 4055
2025
Q4 		$865K Sell
120,870
-117,797
-49% -$837K ﹤0.01% 1808
2025
Q3 		$1.8M Buy
+238,667
New +$1.74M 0.01% 1198
2024
Q1 		– Sell
-22,481
Closed -$106K – 2521
2023
Q4 		$106K Sell
22,481
-91,590
-80% -$391K ﹤0.01% 1883
2023
Q3 		$554K Buy
+114,071
New +$703K 0.01% 1359
2023
Q2 		– Sell
-24,795
Closed -$77K – 2679
2023
Q1 		$77K Buy
+24,795
New +$70.8K ﹤0.01% 2096
2022
Q2 		– Sell
-17,097
Closed -$45K – 3133
2022
Q1 		$45K Sell
17,097
-107,087
-86% -$350K ﹤0.01% 2758
2021
Q4 		$553K Buy
+124,184
New +$697K ﹤0.01% 1673

Other funds holding EVLV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SPCM
Stoic Point Capital Management Palo Alto, California $103M AUM
DCI
Data Collective IV Palo Alto, California $55.9M AUM 49.14% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

HRT Financial's EVLV Position: Q1 2026 in Review

HRT Financial sold out of Evolv Technologies (EVLV) in Q1 2026, closing a stake of 120,870 shares — an estimated $865K sold.

HRT Financial first reported a position in EVLV in Q4 2021 and held it in 7 quarters. The position peaked at $1.8M in Q3 2025. 260 funds tracked by Wall St. Rank hold EVLV as of Q1 2026.

  • HRT Financial reported no remaining Evolv Technologies position as of Q1 2026 after selling out during the quarter.
  • HRT Financial sold 120,870 Evolv Technologies shares in Q1 2026, an estimated $865K.
  • HRT Financial first reported a position in Evolv Technologies in Q4 2021 and held it in 7 quarters.
  • HRT Financial's Evolv Technologies position peaked at $1.8M in Q3 2025.
  • 260 funds tracked by Wall St. Rank held Evolv Technologies as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.